Novel mRNA vaccine GLB-COV2-043 shows high efficacy against COVID-19 variants in early trials Post author: Post published:December 5, 2023 Post category:uncategorized The safety, efficacy, and immunogenicity of a mRNA-based vaccine. You Might Also Like Study unravels FOXO1’s influence on blood vessel development March 9, 2024 KFF Health News’ ‘What the Health?’: Nursing home staffing rules prompt pushback June 6, 2024 SCA4 genetic breakthrough: Unveiling the cause of a devastating neurological disease April 29, 2024